Starpharma’s (ASX:SPL) antiviral agent fights back against against influenza virus
Starpharma’s (SPL) antiviral agent achieves up to 99.7 per cent reduction in…
Starpharma Holdings Limited (ASX:SPL)
About Starpharma Holdings Limited
Key Information
SPL In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 27/05/2022 | Notification of cessation of securities - SPL | 21.51KB | 317 |
| 27/05/2022 | Application for quotation of securities - SPL | 26.57KB | 1.1K |
| 18/05/2022 | Price Sensitive PS SPL7013 in VIRALEZE virucidal against influenza A and B | 281.77KB | 5.6K |
| 29/04/2022 | Price Sensitive PS Quarterly Cashflow and Activities Report | 357.52KB | 7.7K |
| 28/04/2022 | Change in substantial holding | 170.7KB | 9.4K |
| 27/04/2022 | Starpharma to present DEP at Boston ADC summit | 224.42KB | 3.3K |
| 01/04/2022 | Dr Jeff Davies appointed as director and Appendix 3X | 381.89KB | 4.4K |
| 01/04/2022 | Price Sensitive PS VIRALEZE to relaunch in the UK | 257.72KB | 20K |